What Can you Expect at the Premium TCE Summit Europe 2026?
The 2nd T-Cell Engager Therapeutics Summit Europe is the only industry-led European forum exclusively focussed on accelerating the development of safe and effective TCEs across oncology and emerging autoimmune indications.
This niche, intimate meeting brings together leaders in Immunology, Preclinical Development, Translational Research, Antibody Engineering, and Immuno-Oncology to address the field’s toughest challenges: optimising tumour selectivity, managing toxicity, enhancing T-cell fitness, and advancing TCE durability and efficacy.
At the 2026 event, expect immersive workshops, data-driven presentations, deep dive discussions and dedicated networking opportunities to equip you with the insights, data, and strategies needed to transform immunotherapy pipelines. Gain actionable insights into target selection, novel engineering approaches and translational strategies that are shaping the next generation of immunotherapies.
Unmissable Event Highlights
GAIN
GAIN insights into emerging technologies for discovering clean, tumour-selective and novel targets for greater safety of treatments, with insights from iOmx Therapeutics and Enara Bio
UNCOVER
UNCOVER the next generation TCE design, from conditional activation to co-stimulation, for enhancing safety and specificity to improve solid tumour treatments, with insights from Molecular Partners, Cytospire Therapeutics and Scancell
DEEP DIVE
DEEP DIVE into new and innovative engineering approaches for improving TCE selectivity to overcome on-target/off-tissue toxicities, with insights from GSK, VERAXA Biotech and Roche
DEEP DIVE
DEEP DIVE into new and innovative engineering approaches for improving TCE selectivity to overcome on-target/off-tissue toxicities, with insights from GSK, VERAXA Biotech and Roche
ADVANCE
ADVANCE TCE programs towards approval with translational and clinical insights to overcome resistance and optimise preclinical assessment strategies, with insights from AstraZeneca, Genmab and T-Cypher Bio
What's New for 2026
New Industry Leading Speakers
10+ Brand new companies on the speaker faculty, hear fresh perspectives from GSK, Enara Bio, Triptych Therapeutics, VERAXA Biotech, Cytospire Therapeutics, LabGenius Therapeutics, Genmab and more to explore new target selection strategies, engineering approaches, and safety assessments for translating more durable, selective and efficacious therapeutics towards approval.
Brand New Data Being Presented
iOmx Therapeutics, T-Cypher Bio, Ability Biotherapeutics, Synolo Therapeutics, Immunocore, Roche, Scancell, and many others will be sharing never before seen data during in-depth, technical case studies for advancing transformative immunotherapies for oncology and autoimmune indications towards the patients in need.
Broader Networking Opportunities
More curated networking sessions, including interactive roundtables, workshop sessions, panel discussions, and speed networking opportunities to enable you to join forces with other TCE experts and collectively face challenges limiting safety and therapeutic index of cell engagers.
Explore the Full Event Guide
- 21+ expert speakers from pioneering biotech and large pharma, including GSK, Cytospire Therapeutics, AstraZeneca, Enara Bio, T-Cypher Bio, Immunocore, Synolo Therapeutics, Roche and more
- Gain in-depth data-driven insights into achieving selective targeting of tumour-specific antigens, novel engineering approaches and emerging opportunities for TCEs in oncology and autoimmune diseases
- 5 interactive workshops and panel discussions to solve challenges in resistance, T cell exhaustion and on-target/off-tissue tissue to accelerate more efficacious and potent TCEs towards the clinic
Attending Companies Include
Explore the Agenda
Discover the latest breakthroughs shaping TCE development, from novel target selection strategies and innovative engager engineering approaches to translational and clinical insights. Gain exclusive insights from industry leaders during data-driven presentations, interactive workshops and expert panel discussions.
Partner With Us
Showcase your solutions alongside other leading solution providers to a community dedicated to cutting-edge TCE innovation. Position your brand at the heart of the biopharma deals and partnerships defining oncology and autoimmune disease pipelines.
Join TCE Experts
Connect with TCE innovators and engage in the hottest conversations propelling safe and efficacious TCE development. During the dedicated networking sessions, make critical connections, and build meaningful collaborations.